APA (7th ed.) Citation

A, L., A, C., C, M., A, M., R, M., R, N., . . . L, P. (2022). No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection. The Journal of clinical endocrinology and metabolism, 107(3), e1009. https://doi.org/10.1210/clinem/dgab792

Chicago Style (17th ed.) Citation

A, Laurenzi, et al. "No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection." The Journal of Clinical Endocrinology and Metabolism 107, no. 3 (2022): e1009. https://doi.org/10.1210/clinem/dgab792.

MLA (9th ed.) Citation

A, Laurenzi, et al. "No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection." The Journal of Clinical Endocrinology and Metabolism, vol. 107, no. 3, 2022, p. e1009, https://doi.org/10.1210/clinem/dgab792.